E. Muñoz-Islas

Role of 5-HT5A and 5-HT1B/1D receptors in the antinociception produced by ergotamine and valerenic acid in the rat formalin test.

V. Granados-Soto, C. Villalón, G. Vidal-Cantú, 2016, European journal of pharmacology.

Spinal 5-HT5A receptors mediate 5-HT-induced antinociception in several pain models in rats

V. Granados-Soto, P. Barragán-Iglesias, C. Cervantes-Durán, 2014, Pharmacology Biochemistry and Behavior.

The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.

G. Manrique-Maldonado, A. González-Hernández, C. Villalón, 2011, European journal of pharmacology.

Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.

A. González-Hernández, C. Villalón, E. Ramírez-San Juan, 2010, European journal of pharmacology.

Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.

L. Cobos-Puc, H. Pertz, A. González-Hernández, 2009, European journal of pharmacology.

Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases

B. Marichal-Cancino, A. González-Hernández, C. Villalón, 2016, BioMed research international.

Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models

J. M. Jimenez-Andrade, R. I. Acosta-González, A. Martínez-Martínez, 2020, Pharmacological Reports.